Isolation of ECFC from patients with HHT demonstrated reduced endoglin expression, impaired TGF-β signaling, disorganized cytoskeleton, and impaired angiogenic ability in a Matrigel assay compared to healthy controls (33). The gene discussed is TGFB1; the disease is hereditary hemorrhagic telangiectasia.